The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
PropertyValue
has major subject area list Recombinant Fusion Proteins; Sjogren's Syndrome
information resource reference Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
label Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
Search Criteria
  • Sjogren
  • s
  • Syndrome